Search Results for “brca” - Page 15 - Ovarian Cancer Research Alliance

Veliparib Trial Fails to Improve Outcomes in Ovarian Cancer

...with cyclophosphamide alone, according to a phase II study evaluating patients with high-grade serous ovarian cancer, peritoneal, fallopian tube, and BRCA-mutant ovarian cancers. The research was reported in Clinical Cancer...

OCRA Awards Millions in New Ovarian Cancer Research Grants

...for Immunology, “Studying the role of BRCA1 in regulating heterochromatin structure and function in ovarian cancer” Bojana Stefanovska, PhD, University of Minnesota – Twin Cities, “APOBEC3B and DNA Repair as...

Niraparib Approved for Maintenance Treatment of Ovarian Cancer

...to be approved by the FDA that does not require BRCA mutation or other biomarker testing. TESARO anticipates launching niraparib in the United States in late April. READ MORE… 11...

A New Report from USPSTF

...in improving benefits and reducing harmful outcomes.” The report also calls for genetic counseling for women with increased risk of BRCA mutations. The USPSTF is an independent panel of health...

Some Fallopian Tube Lesions Represent Ovarian Cancer Metastases, Not Precursor Lesions

...population levels. In studying the origin of HGSC, it remains important to separate cases driven by germline mutations in BRCA1/2 or other ovarian cancer susceptibility genes from sporadic carcinomas. Eckert...

At Your Own Pace, In Your Own Space: How to Be a Hero in a Pandemic

...in her abdomen that Amy learned she had ovarian cancer. (She also had genetic testing and learned that she was positive for the BRCA gene mutation.) A project is born...

Impact of Genetic Counseling on Testing and Surgical Prevention in High Risk Women

...and prophylactic surgery. Guidelines recommend genetic counseling and testing for women who have a pedigree suggestive of an inherited susceptibility for ovarian cancer (for example, BRCA1 and 2 genes). The...

Ask the SAC | Why Is the Number of Ovarian Cancer Diagnoses Decreasing?

...risk-reducing surgery in patients with BRCA or other high-risk mutations, and increase in opportunistic salpingectomy.” “Likely many reasons — more use of oral contraceptive pills (OCPs), less hormone replacement, better awareness,...

Our Response to Angelina

...that she has a mutation in the BRCA gene, which increases her risk of breast and ovarian cancers. The Alliance received many calls and requests to comment from media outlets....

Highlights from American Society of Clinical Oncology’s Annual Meeting

...a good choice for elderly ovarian cancer patients Evaluating Olaparib for BRCA Wild-Type Platinum-Resistant Ovarian Cancer Benefit of Olaparib vs Chemo in Platinum-Sensitive Relapsed Ovarian Cancer Niraparib plus bevacizumab significantly...

Need to talk?

Free Genetic Testing Program

Harnessing AI for Early Detection

We Need Your Voice

Become a Monthly Donor

OCRA Joins Forces with Rivkin Center

Suggested Links

Quick Links

Suggested Links

Quick Links

Search Results for: "brca"

Search Again

Veliparib Trial Fails to Improve Outcomes in Ovarian Cancer

OCRA Awards Millions in New Ovarian Cancer Research Grants

Niraparib Approved for Maintenance Treatment of Ovarian Cancer

A New Report from USPSTF

Some Fallopian Tube Lesions Represent Ovarian Cancer Metastases, Not Precursor Lesions

At Your Own Pace, In Your Own Space: How to Be a Hero in a Pandemic

Impact of Genetic Counseling on Testing and Surgical Prevention in High Risk Women

Ask the SAC | Why Is the Number of Ovarian Cancer Diagnoses Decreasing?

Our Response to Angelina

Highlights from American Society of Clinical Oncology’s Annual Meeting

Stay Informed

Quick Links

About